Application 210136
- Type
- NDA
- Sponsor
- BRAEBURN PHARMA INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | BRIXADI | BUPRENORPHINE | INJECTION, EXTENDED RELEASE;SUBCUTANEOUS | 8MG | No | No |
| 002 | BRIXADI | BUPRENORPHINE | SOLUTION, EXTENDED RELEASE;SUBCUTANEOUS | 16MG/0.32ML (50MG/ML) | Yes | Yes |
| 003 | BRIXADI | BUPRENORPHINE | SOLUTION, EXTENDED RELEASE;SUBCUTANEOUS | 24MG/0.48ML (50MG/ML) | Yes | Yes |
| 004 | BRIXADI | BUPRENORPHINE | SOLUTION, EXTENDED RELEASE;SUBCUTANEOUS | 32MG/0.64ML (50MG/ML) | Yes | Yes |
| 005 | BRIXADI | BUPRENORPHINE | SOLUTION, EXTENDED RELEASE;SUBCUTANEOUS | 64MG/0.18ML (356MG/ML) | Yes | Yes |
| 006 | BRIXADI | BUPRENORPHINE | SOLUTION, EXTENDED RELEASE;SUBCUTANEOUS | 96MG/0.27ML (356MG/ML) | Yes | Yes |
| 007 | BRIXADI | BUPRENORPHINE | SOLUTION, EXTENDED RELEASE;SUBCUTANEOUS | 128MG/0.36ML (356MG/ML) | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N210136-001 | BRIXADI | BUPRENORPHINE | 8MG/0.16ML (50MG/ML) | SOLUTION, EXTENDED RELEASE / SUBCUTANEOUS | RLD, RS | 2023-05-23 | |
| N210136-002 | BRIXADI | BUPRENORPHINE | 16MG/0.32ML (50MG/ML) | SOLUTION, EXTENDED RELEASE / SUBCUTANEOUS | RLD, RS | 2023-05-23 | |
| N210136-003 | BRIXADI | BUPRENORPHINE | 24MG/0.48ML (50MG/ML) | SOLUTION, EXTENDED RELEASE / SUBCUTANEOUS | RLD, RS | 2023-05-23 | |
| N210136-004 | BRIXADI | BUPRENORPHINE | 32MG/0.64ML (50MG/ML) | SOLUTION, EXTENDED RELEASE / SUBCUTANEOUS | RLD, RS | 2023-05-23 | |
| N210136-005 | BRIXADI | BUPRENORPHINE | 64MG/0.18ML (356MG/ML) | SOLUTION, EXTENDED RELEASE / SUBCUTANEOUS | RLD, RS | 2023-05-23 | |
| N210136-006 | BRIXADI | BUPRENORPHINE | 96MG/0.27ML (356MG/ML) | SOLUTION, EXTENDED RELEASE / SUBCUTANEOUS | RLD, RS | 2023-05-23 | |
| N210136-007 | BRIXADI | BUPRENORPHINE | 128MG/0.36ML (356MG/ML) | SOLUTION, EXTENDED RELEASE / SUBCUTANEOUS | RLD, RS | 2023-05-23 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N210136-001 | 8236755 | 2026-07-31 | U-3620 | Drug product | 2023-06-06 |
| N210136-001 | 8236292 | 2027-01-10 | U-3619 | Drug product | 2023-06-06 |
| N210136-001 | 10912772 | 2032-07-26 | U-3617 | 2023-06-06 | |
| N210136-001 | 11110084 | 2032-07-26 | U-3616 | Drug product | 2023-06-06 |
| N210136-001 | 11135215 | 2032-07-26 | Drug product | 2023-06-06 | |
| N210136-001 | 12161640 | 2032-07-26 | U-4100 | Drug product | 2025-01-08 |
| N210136-001 | 12318379 | 2032-07-26 | U-4100 | Drug product | 2025-06-30 |
| N210136-001 | 9937164 | 2032-07-26 | U-3618 | Drug product | 2023-06-06 |
| N210136-002 | 8236755 | 2026-07-31 | U-3620 | Drug product | 2023-06-06 |
| N210136-002 | 8236292 | 2027-01-10 | U-3619 | Drug product | 2023-06-06 |
| N210136-002 | 10912772 | 2032-07-26 | U-3617 | 2023-06-06 | |
| N210136-002 | 11110084 | 2032-07-26 | U-3616 | Drug product | 2023-06-06 |
| N210136-002 | 11135215 | 2032-07-26 | Drug product | 2023-06-06 | |
| N210136-002 | 12161640 | 2032-07-26 | U-4100 | Drug product | 2025-01-08 |
| N210136-002 | 12318379 | 2032-07-26 | U-4100 | Drug product | 2025-06-30 |
| N210136-002 | 9937164 | 2032-07-26 | U-3618 | Drug product | 2023-06-06 |
| N210136-003 | 8236755 | 2026-07-31 | U-3620 | Drug product | 2023-06-06 |
| N210136-003 | 8236292 | 2027-01-10 | U-3619 | Drug product | 2023-06-06 |
| N210136-003 | 10912772 | 2032-07-26 | U-3617 | 2023-06-06 | |
| N210136-003 | 11110084 | 2032-07-26 | U-3616 | Drug product | 2023-06-06 |
| N210136-003 | 11135215 | 2032-07-26 | Drug product | 2023-06-06 | |
| N210136-003 | 12161640 | 2032-07-26 | U-4100 | Drug product | 2025-01-08 |
| N210136-003 | 12318379 | 2032-07-26 | U-4100 | Drug product | 2025-06-30 |
| N210136-003 | 9937164 | 2032-07-26 | U-3618 | Drug product | 2023-06-06 |
| N210136-004 | 8236755 | 2026-07-31 | U-3620 | Drug product | 2023-06-06 |
| N210136-004 | 8236292 | 2027-01-10 | U-3619 | Drug product | 2023-06-06 |
| N210136-004 | 10912772 | 2032-07-26 | U-3617 | 2023-06-06 | |
| N210136-004 | 11110084 | 2032-07-26 | U-3616 | Drug product | 2023-06-06 |
| N210136-004 | 11135215 | 2032-07-26 | Drug product | 2023-06-06 | |
| N210136-004 | 12161640 | 2032-07-26 | U-4100 | Drug product | 2025-01-08 |
| N210136-004 | 12318379 | 2032-07-26 | U-4100 | Drug product | 2025-06-30 |
| N210136-004 | 9937164 | 2032-07-26 | U-3618 | Drug product | 2023-06-06 |
| N210136-005 | 8236755 | 2026-07-31 | U-3620 | Drug product | 2023-06-06 |
| N210136-005 | 8236292 | 2027-01-10 | U-3619 | Drug product | 2023-06-06 |
| N210136-005 | 10912772 | 2032-07-26 | U-3617 | 2023-06-06 | |
| N210136-005 | 11110084 | 2032-07-26 | U-3616 | Drug product | 2023-06-06 |
| N210136-005 | 11135215 | 2032-07-26 | Drug product | 2023-06-06 | |
| N210136-005 | 12161640 | 2032-07-26 | U-4100 | Drug product | 2025-01-08 |
| N210136-005 | 12318379 | 2032-07-26 | U-4100 | Drug product | 2025-06-30 |
| N210136-005 | 9937164 | 2032-07-26 | U-3618 | Drug product | 2023-06-06 |
| N210136-006 | 8236755 | 2026-07-31 | U-3620 | Drug product | 2023-06-06 |
| N210136-006 | 8236292 | 2027-01-10 | U-3619 | Drug product | 2023-06-06 |
| N210136-006 | 10912772 | 2032-07-26 | U-3617 | 2023-06-06 | |
| N210136-006 | 11110084 | 2032-07-26 | U-3616 | Drug product | 2023-06-06 |
| N210136-006 | 11135215 | 2032-07-26 | Drug product | 2023-06-06 | |
| N210136-006 | 12161640 | 2032-07-26 | U-4100 | Drug product | 2025-01-08 |
| N210136-006 | 12318379 | 2032-07-26 | U-4100 | Drug product | 2025-06-30 |
| N210136-006 | 9937164 | 2032-07-26 | U-3618 | Drug product | 2023-06-06 |
| N210136-007 | 8236755 | 2026-07-31 | U-3620 | Drug product | 2023-06-06 |
| N210136-007 | 8236292 | 2027-01-10 | U-3619 | Drug product | 2023-06-06 |
| N210136-007 | 10912772 | 2032-07-26 | U-3617 | 2023-06-06 | |
| N210136-007 | 11110084 | 2032-07-26 | U-3616 | Drug product | 2023-06-06 |
| N210136-007 | 11135215 | 2032-07-26 | Drug product | 2023-06-06 | |
| N210136-007 | 12161640 | 2032-07-26 | U-4100 | Drug product | 2025-01-08 |
| N210136-007 | 12318379 | 2032-07-26 | U-4100 | Drug product | 2025-06-30 |
| N210136-007 | 9937164 | 2032-07-26 | U-3618 | Drug product | 2023-06-06 |
Orange Book exclusivity#
| Application-product | Exclusivity code | Expiration |
|---|---|---|
| N210136-001 | NP | 2026-05-23 |
| N210136-002 | NP | 2026-05-23 |
| N210136-003 | NP | 2026-05-23 |
| N210136-004 | NP | 2026-05-23 |
| N210136-005 | NP | 2026-05-23 |
| N210136-006 | NP | 2026-05-23 |
| N210136-007 | NP | 2026-05-23 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N210136-001 | BRIXADI | 8MG/0.16ML (50MG/ML) | SOLUTION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2023-05-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N210136-002 | BRIXADI | 16MG/0.32ML (50MG/ML) | SOLUTION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2023-05-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N210136-003 | BRIXADI | 24MG/0.48ML (50MG/ML) | SOLUTION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2023-05-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N210136-004 | BRIXADI | 32MG/0.64ML (50MG/ML) | SOLUTION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2023-05-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N210136-005 | BRIXADI | 64MG/0.18ML (356MG/ML) | SOLUTION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2023-05-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N210136-006 | BRIXADI | 96MG/0.27ML (356MG/ML) | SOLUTION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2023-05-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N210136-007 | BRIXADI | 128MG/0.36ML (356MG/ML) | SOLUTION, EXTENDED RELEASE / SUBCUTANEOUS | RLD, RS | 2023-05-23 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210136-001 | BRIXADI | 8MG/0.16ML (50MG/ML) | SOLUTION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2023-05-23 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210136-002 | BRIXADI | 16MG/0.32ML (50MG/ML) | SOLUTION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2023-05-23 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210136-003 | BRIXADI | 24MG/0.48ML (50MG/ML) | SOLUTION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2023-05-23 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210136-004 | BRIXADI | 32MG/0.64ML (50MG/ML) | SOLUTION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2023-05-23 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210136-005 | BRIXADI | 64MG/0.18ML (356MG/ML) | SOLUTION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2023-05-23 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210136-006 | BRIXADI | 96MG/0.27ML (356MG/ML) | SOLUTION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2023-05-23 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210136-007 | BRIXADI | 128MG/0.36ML (356MG/ML) | SOLUTION, EXTENDED RELEASE / SUBCUTANEOUS | RLD, RS | 2023-05-23 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N210136-001 | BRIXADI | 8MG/0.16ML (50MG/ML) | SOLUTION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2023-05-23 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N210136-002 | BRIXADI | 16MG/0.32ML (50MG/ML) | SOLUTION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2023-05-23 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N210136-003 | BRIXADI | 24MG/0.48ML (50MG/ML) | SOLUTION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2023-05-23 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N210136-004 | BRIXADI | 32MG/0.64ML (50MG/ML) | SOLUTION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2023-05-23 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N210136-005 | BRIXADI | 64MG/0.18ML (356MG/ML) | SOLUTION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2023-05-23 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N210136-006 | BRIXADI | 96MG/0.27ML (356MG/ML) | SOLUTION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2023-05-23 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N210136-007 | BRIXADI | 128MG/0.36ML (356MG/ML) | SOLUTION, EXTENDED RELEASE / SUBCUTANEOUS | RLD, RS | 2023-05-23 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N210136-001 | BRIXADI | 8MG/0.16ML (50MG/ML) | SOLUTION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2023-05-23 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N210136-002 | BRIXADI | 16MG/0.32ML (50MG/ML) | SOLUTION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2023-05-23 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N210136-003 | BRIXADI | 24MG/0.48ML (50MG/ML) | SOLUTION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2023-05-23 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N210136-004 | BRIXADI | 32MG/0.64ML (50MG/ML) | SOLUTION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2023-05-23 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N210136-005 | BRIXADI | 64MG/0.18ML (356MG/ML) | SOLUTION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2023-05-23 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N210136-006 | BRIXADI | 96MG/0.27ML (356MG/ML) | SOLUTION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2023-05-23 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N210136-007 | BRIXADI | 128MG/0.36ML (356MG/ML) | SOLUTION, EXTENDED RELEASE / SUBCUTANEOUS | RLD, RS | 2023-05-23 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N210136-001 | BRIXADI | 8MG/0.16ML (50MG/ML) | SOLUTION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2023-05-23 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N210136-002 | BRIXADI | 16MG/0.32ML (50MG/ML) | SOLUTION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2023-05-23 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N210136-003 | BRIXADI | 24MG/0.48ML (50MG/ML) | SOLUTION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2023-05-23 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N210136-004 | BRIXADI | 32MG/0.64ML (50MG/ML) | SOLUTION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2023-05-23 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N210136-005 | BRIXADI | 64MG/0.18ML (356MG/ML) | SOLUTION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2023-05-23 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N210136-006 | BRIXADI | 96MG/0.27ML (356MG/ML) | SOLUTION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2023-05-23 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N210136-007 | BRIXADI | 128MG/0.36ML (356MG/ML) | SOLUTION, EXTENDED RELEASE / SUBCUTANEOUS | RLD, RS | 2023-05-23 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N210136-001 | BRIXADI | 8MG/0.16ML (50MG/ML) | SOLUTION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2023-05-23 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N210136-002 | BRIXADI | 16MG/0.32ML (50MG/ML) | SOLUTION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2023-05-23 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N210136-003 | BRIXADI | 24MG/0.48ML (50MG/ML) | SOLUTION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2023-05-23 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N210136-004 | BRIXADI | 32MG/0.64ML (50MG/ML) | SOLUTION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2023-05-23 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N210136-005 | BRIXADI | 64MG/0.18ML (356MG/ML) | SOLUTION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2023-05-23 | 03ed91905a0d… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N210136-001 | 8236755 | 2026-07-31 | U-3620 | Drug product | 2023-06-06 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N210136-001 | 8236292 | 2027-01-10 | U-3619 | Drug product | 2023-06-06 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N210136-001 | 10912772 | 2032-07-26 | U-3617 | 2023-06-06 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N210136-001 | 11110084 | 2032-07-26 | U-3616 | Drug product | 2023-06-06 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N210136-001 | 11135215 | 2032-07-26 | Drug product | 2023-06-06 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N210136-001 | 12161640 | 2032-07-26 | U-4100 | Drug product | 2025-01-08 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N210136-001 | 12318379 | 2032-07-26 | U-4100 | Drug product | 2025-06-30 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N210136-001 | 9937164 | 2032-07-26 | U-3618 | Drug product | 2023-06-06 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N210136-002 | 8236755 | 2026-07-31 | U-3620 | Drug product | 2023-06-06 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N210136-002 | 8236292 | 2027-01-10 | U-3619 | Drug product | 2023-06-06 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N210136-002 | 10912772 | 2032-07-26 | U-3617 | 2023-06-06 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N210136-002 | 11110084 | 2032-07-26 | U-3616 | Drug product | 2023-06-06 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N210136-002 | 11135215 | 2032-07-26 | Drug product | 2023-06-06 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N210136-002 | 12161640 | 2032-07-26 | U-4100 | Drug product | 2025-01-08 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N210136-002 | 12318379 | 2032-07-26 | U-4100 | Drug product | 2025-06-30 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N210136-002 | 9937164 | 2032-07-26 | U-3618 | Drug product | 2023-06-06 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N210136-003 | 8236755 | 2026-07-31 | U-3620 | Drug product | 2023-06-06 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N210136-003 | 8236292 | 2027-01-10 | U-3619 | Drug product | 2023-06-06 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N210136-003 | 10912772 | 2032-07-26 | U-3617 | 2023-06-06 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N210136-003 | 11110084 | 2032-07-26 | U-3616 | Drug product | 2023-06-06 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N210136-003 | 11135215 | 2032-07-26 | Drug product | 2023-06-06 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N210136-003 | 12161640 | 2032-07-26 | U-4100 | Drug product | 2025-01-08 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N210136-003 | 12318379 | 2032-07-26 | U-4100 | Drug product | 2025-06-30 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N210136-003 | 9937164 | 2032-07-26 | U-3618 | Drug product | 2023-06-06 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N210136-004 | 8236755 | 2026-07-31 | U-3620 | Drug product | 2023-06-06 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N210136-004 | 8236292 | 2027-01-10 | U-3619 | Drug product | 2023-06-06 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N210136-004 | 10912772 | 2032-07-26 | U-3617 | 2023-06-06 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N210136-004 | 11110084 | 2032-07-26 | U-3616 | Drug product | 2023-06-06 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N210136-004 | 11135215 | 2032-07-26 | Drug product | 2023-06-06 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N210136-004 | 12161640 | 2032-07-26 | U-4100 | Drug product | 2025-01-08 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N210136-004 | 12318379 | 2032-07-26 | U-4100 | Drug product | 2025-06-30 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N210136-004 | 9937164 | 2032-07-26 | U-3618 | Drug product | 2023-06-06 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N210136-005 | 8236755 | 2026-07-31 | U-3620 | Drug product | 2023-06-06 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N210136-005 | 8236292 | 2027-01-10 | U-3619 | Drug product | 2023-06-06 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N210136-005 | 10912772 | 2032-07-26 | U-3617 | 2023-06-06 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N210136-005 | 11110084 | 2032-07-26 | U-3616 | Drug product | 2023-06-06 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N210136-005 | 11135215 | 2032-07-26 | Drug product | 2023-06-06 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N210136-005 | 12161640 | 2032-07-26 | U-4100 | Drug product | 2025-01-08 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N210136-005 | 12318379 | 2032-07-26 | U-4100 | Drug product | 2025-06-30 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N210136-005 | 9937164 | 2032-07-26 | U-3618 | Drug product | 2023-06-06 | 011fe1cb6892… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N210136-001 | NP | 2026-05-23 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N210136-002 | NP | 2026-05-23 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N210136-003 | NP | 2026-05-23 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N210136-004 | NP | 2026-05-23 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N210136-005 | NP | 2026-05-23 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N210136-006 | NP | 2026-05-23 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N210136-007 | NP | 2026-05-23 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210136-001 | NP | 2026-05-23 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210136-002 | NP | 2026-05-23 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210136-003 | NP | 2026-05-23 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210136-004 | NP | 2026-05-23 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210136-005 | NP | 2026-05-23 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210136-006 | NP | 2026-05-23 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210136-007 | NP | 2026-05-23 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N210136-001 | NP | 2026-05-23 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N210136-002 | NP | 2026-05-23 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N210136-003 | NP | 2026-05-23 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N210136-004 | NP | 2026-05-23 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N210136-005 | NP | 2026-05-23 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N210136-006 | NP | 2026-05-23 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N210136-007 | NP | 2026-05-23 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N210136-001 | NP | 2026-05-23 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N210136-002 | NP | 2026-05-23 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N210136-003 | NP | 2026-05-23 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N210136-004 | NP | 2026-05-23 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N210136-005 | NP | 2026-05-23 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N210136-006 | NP | 2026-05-23 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N210136-007 | NP | 2026-05-23 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N210136-001 | NP | 2026-05-23 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N210136-002 | NP | 2026-05-23 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N210136-003 | NP | 2026-05-23 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N210136-004 | NP | 2026-05-23 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N210136-005 | NP | 2026-05-23 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N210136-006 | NP | 2026-05-23 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N210136-007 | NP | 2026-05-23 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N210136-001 | NP | 2026-05-23 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N210136-002 | NP | 2026-05-23 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N210136-003 | NP | 2026-05-23 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N210136-004 | NP | 2026-05-23 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N210136-005 | NP | 2026-05-23 | 03ed91905a0d… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BRIXADI | BUPRENORPHINE | Braeburn Inc. | 5d8a8fd0-8619-422a-a664-d1d2e8970f48 | 2025-12-31 | Boxed warning, Warnings, Adverse reactions | 210136 NDA210136 |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 85203 | SUPPL | 2026-03-02 |
| 84642 | SUPPL | 2026-01-05 |
| 84585 | SUPPL | 2025-12-29 |
| 83284 | SUPPL | 2025-09-04 |
| 81895 | SUPPL | 2025-04-09 |
| 77924 | ORIG | 2024-03-25 |
| 77049 | SUPPL | 2023-12-19 |
| 77044 | SUPPL | 2023-12-19 |
| 74355 | ORIG | 2023-11-06 |
| 74358 | ORIG | 2023-05-23 |
| 74357 | ORIG | 2023-05-23 |
| 57788 | ORIG | 2019-02-22 |